Becker's Healthcare June 24, 2025
A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin altogether.
The research, published June 20 in The New England Journal of Medicine, consisted of a phase 1-2 clinical trial testing zimislecel, an allogeneic stem cell-derived islet-cell therapy in 14 patients with Type 1 diabetes....







